Relating to xylazine.

HB 2103 requires the Oregon State Board of Pharmacy to adopt rules classifying xylazine as a Schedule IV controlled substance. This means xylazine would be regulated under state law as a controlled substance with accepted medical uses but potential for abuse, affecting how it can be prescribed or dispensed. The bill directly impacts the State Board of Pharmacy, which must create specific rules for this classification. It does not change current federal scheduling or address xylazine's use in veterinary medicine. The bill is currently in committee and has not yet been voted on.